Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Carevive Systems, Inc.
Essen Biotech
Colorado State University
Ohio State University Comprehensive Cancer Center
Mayo Clinic
AC Camargo Cancer Center
Incyte Corporation
M.D. Anderson Cancer Center
University of Colorado, Denver
Arab American University (Palestine)
Washington University School of Medicine
University of Alabama at Birmingham
Baxter Healthcare Corporation
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Cedars-Sinai Medical Center
Universidade Federal de Pernambuco
Cyteir Therapeutics, Inc.
Cedars-Sinai Medical Center
OHSU Knight Cancer Institute
Scripps Health
Novartis
Celgene
InSightec
AbbVie
City of Hope Medical Center
Incyte Corporation
The Christie NHS Foundation Trust
Alliance for Clinical Trials in Oncology
Amgen
Wake Forest University Health Sciences
Stanford University
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Alliance for Clinical Trials in Oncology
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
University of Louisville
Fred Hutchinson Cancer Center
Rutgers, The State University of New Jersey
Shenzhen Second People's Hospital
Celldex Therapeutics
M.D. Anderson Cancer Center
Barbara Ann Karmanos Cancer Institute
The Cleveland Clinic
National Cancer Institute (NCI)
Indiana University
University of Minnesota
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins